| Tubulin in platelets: when the shape matters EJ Cuenca-Zamora, F Ferrer-Marín, J Rivera, R Teruel-Montoya International journal of molecular sciences 20 (14), 3484, 2019 | 66 | 2019 |
| Qualitative and quantitative comparison of plasma exosomes from neonates and adults J Peñas-Martínez, MN Barrachina, EJ Cuenca-Zamora, G Luengo-Gil, ... International journal of molecular sciences 22 (4), 1926, 2021 | 26 | 2021 |
| Emerging role of neutrophils in the thrombosis of chronic myeloproliferative neoplasms F Ferrer-Marín, EJ Cuenca-Zamora, PJ Guijarro-Carrillo, ... International Journal of Molecular Sciences 22 (3), 1143, 2021 | 25 | 2021 |
| miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk F Ferrer-Marín, AB Arroyo, B Bellosillo, EJ Cuenca, L Zamora, ... Leukemia 34 (10), 2648-2659, 2020 | 21 | 2020 |
| NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical … S Carrillo‐Tornel, TH Chen‐Liang, M Zurdo, A Puiggros, A Gómez‐Llonín, ... British Journal of Haematology 201 (3), 470-479, 2023 | 3 | 2023 |
| MicroRNAs in platelets: should i stay or should i go S Águila, E Cuenca-Zamora, C Martínez, R Teruel-Montoya Platelets, 2020 | 3 | 2020 |
| Correction: Cuenca-Zamora, Ernesto José., et al. Tubulin in Platelets: When the Shape Matter. Int. J. Mol. Sci. 2019, 20, 3484 EJ Cuenca-Zamora, F Ferrer-Marín, J Rivera, R Teruel-Montoya International Journal of Molecular Sciences 21 (10), 3577, 2020 | 2 | 2020 |
| NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy L Hurtado-Navarro, EJ Cuenca-Zamora, L Zamora, B Bellosillo, E Such, ... Cell Reports Medicine 4 (12), 2023 | 1 | 2023 |
| Table 1. Clinical-biological and molecular characteristics of CML patients in each group evaluated S Agula, E Cuenca-Zamora, MJ Lis, MS Noya-Pereira, V Gutierrez-Garcia, ... HAEMATOLOGICA 106 (10), 3-4, 2021 | | 2021 |
| STUDY OF THE MECHANISMS OF THROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH TYROSINE KINASE INHIBITORS S Agula, E Cuenca-Zamora, MJ Lis, MS Noya-Pereira, V Gutierrez-Garcia, ... HAEMATOLOGICA 106 (10), 3-3, 2021 | | 2021 |
| VALIDATION OF ELN SURVIVAL AND THROMBOTIC RISK SCALES IN A GROUP OF PATIENTS WITH POLYCYTHEMIA VERA I Mellado, EJ Cuenca-Zamora, MR Teruel, J Padilla, N Bohdan, ... HAEMATOLOGICA 105, 240-241, 2020 | | 2020 |
| THIRD-GENERATION NANOPORE (MINION) SEQUENCING FOR THE DETECTION OF BI-ALLELIC MUTATIONS: APPLICATION TO CEBPA IN PATIENTS WITH ACUTE MYELOID LEUKEMIA B de la Morena-Barrio, C Bravo, J Penas-Martinez, R Cifuentes-Riquelme, ... HAEMATOLOGICA 105, 378-379, 2020 | | 2020 |
| BIOMARKERS OF THROMBOTH RISK IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH PONATINIB S Aguila, EJ Cuenca-Zamora, MJ Lis, L Palomera, MS Noya-Pereira, ... HAEMATOLOGICA 105, 130-131, 2020 | | 2020 |
| THE GERMINAL VARIANTS RS6336/RS6339 OF NTRK1 PREDISPOSE TO CHRONIC MYELOPROLIFERATIVE NEOPLASIAS EJ Cuenca-Zamora, JF Ruiz-Pividal, L Zamora-Plana, B Bellosino, ... HAEMATOLOGICA 104, 59-60, 2019 | | 2019 |
| miR-146a-/-mice model reveals that NF-κB inhibition reverts inflammation-driven myelofibrosis-like phenotype EJ Cuenca-Zamora, PJ Guijarro-Carrillo, MJ López-Poveda, ML Morales, ... American journal of hematology, 0 | | |
Sonia AguilaCentro Regional de Hemodonación, IMIB-ArrixacaVerified email at um.es
